drugset / Trial / NCT01317069
A Randomized, Open, Prospective Clinical Research of Fluorouracil Implant to Improve Surgical Gallbladder Cancer and Bile Duct Cancer
Phase 2
Unknown
100 enrolled
Simcere Pharmaceutical Co., Ltd
Eastern Hepatobiliary Surgery Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Through clinical practice, to explore if the application of Fluorouracil implant could effectively delay the local tumor recurrence and improvement the postoperative survival time in patients with gallbladder cancer and bile duct cancer.
Timeline
- Start
- 2010-06
- Primary completion
- 2012-12
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | fluorouracil | Small molecule | 1000 mg | Other |